These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36356431)

  • 41. Comparative effectiveness and safety of warfarin and dabigatran in patients with non-valvular atrial fibrillation in Japan: A claims database analysis.
    Koretsune Y; Yamashita T; Yasaka M; Ono Y; Hirakawa T; Ishida K; Kuroki D; Sumida T; Urushihara H
    J Cardiol; 2019 Mar; 73(3):204-209. PubMed ID: 30477926
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of glycated hemoglobin on 2-year clinical outcomes in elderly patients with atrial fibrillation: sub-analysis of ANAFIE Registry, a large observational study.
    Terauchi Y; Inoue H; Yamashita T; Akao M; Atarashi H; Ikeda T; Koretsune Y; Okumura K; Suzuki S; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Morishima Y; Takita A; Shimizu W
    Cardiovasc Diabetol; 2023 Jul; 22(1):175. PubMed ID: 37438827
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
    BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH-AFNET 6 Trial.
    Diener HC; Becher N; Sehner S; Toennis T; Bertaglia E; Blomstrom-Lundqvist C; Brandes A; Beuger V; Calvert M; Camm AJ; Chlouverakis G; Dan GA; Dichtl W; Fierenz A; Goette A; de Groot JR; Hermans A; Lip GYH; Lubinski A; Marijon E; Merkely B; Mont L; Nikorowitsch J; Ozga AK; Rajappan K; Sarkozy A; Scherr D; Schnabel RB; Schotten U; Simantirakis E; Vardas P; Wichterle D; Zapf A; Kirchhof P;
    J Am Heart Assoc; 2024 Sep; 13(17):e036429. PubMed ID: 39190564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Halperin JL; Hankey GJ; Wojdyla DM; Piccini JP; Lokhnygina Y; Patel MR; Breithardt G; Singer DE; Becker RC; Hacke W; Paolini JF; Nessel CC; Mahaffey KW; Califf RM; Fox KA;
    Circulation; 2014 Jul; 130(2):138-46. PubMed ID: 24895454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of Direct Oral Anticoagulant and Outcomes in Patients With Atrial Fibrillation after Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry.
    Tanawuttiwat T; Stebbins A; Marquis-Gravel G; Vemulapalli S; Kosinski AS; Cheng A
    J Am Heart Assoc; 2022 Jan; 11(1):e023561. PubMed ID: 34970918
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation.
    Giustozzi M; Agnelli G; Quattrocchi S; Acciarresi M; Alberti A; Caso V; Vedovati MC; Venti M; Paciaroni M
    Cerebrovasc Dis Extra; 2020; 10(2):44-49. PubMed ID: 32375143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ISCHEMIC STROKE AND MAJOR BLEEDING WHILE ON DIRECT ORAL ANTICOAGULANTS IN NAÏVE PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF RESUMPTION OR DISCONTINUATION OF ANTICOAGULANT TREATMENT. A population-based study.
    Gennaro N; Ferroni E; Zorzi M; Denas G; Pengo V
    Int J Cardiol; 2024 Jan; 394():131369. PubMed ID: 37722453
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Direct oral anticoagulants compared with other strategies in patients with atrial fibrillation and stroke or transient ischemic attack: Systematic review.
    Lee KH; Hung WT; Huang WY; Ovbiagele B; Lee M
    J Formos Med Assoc; 2024 May; 123(5):551-560. PubMed ID: 37838540
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intracranial hemorrhage and subsequent ischemic stroke in patients with atrial fibrillation: a nationwide cohort study.
    Brønnum Nielsen P; Larsen TB; Gorst-Rasmussen A; Skjøth F; Rasmussen LH; Lip GYH
    Chest; 2015 Jun; 147(6):1651-1658. PubMed ID: 25412369
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ischemic Stroke and Systemic Embolism Among One-and-Done Direct Oral Anticoagulant Users with Non-valvular Atrial Fibrillation.
    Alberts M; Zhdanava M; Pilon D; Caron-Lapointe G; Lefebvre P; Bookhart B; Kharat A
    Adv Ther; 2023 May; 40(5):2339-2354. PubMed ID: 36947331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and Effectiveness of Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation and Anemia: A Retrospective Cohort Study.
    Wang CL; Wu VC; Huang YT; Kuo CF; Chu PH; Chen YL; Wen MS; Chang SH
    J Am Heart Assoc; 2019 May; 8(9):e012029. PubMed ID: 31020896
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks.
    Aguilar MI; Hart R; Pearce LA
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006186. PubMed ID: 17636831
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.
    Piccini JP; Stevens SR; Chang Y; Singer DE; Lokhnygina Y; Go AS; Patel MR; Mahaffey KW; Halperin JL; Breithardt G; Hankey GJ; Hacke W; Becker RC; Nessel CC; Fox KA; Califf RM;
    Circulation; 2013 Jan; 127(2):224-32. PubMed ID: 23212720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Registry of Japanese patients with atrial fibrillation focused on anticoagulant therapy in the new era: The RAFFINE registry study design and baseline characteristics.
    Miyazaki S; Miyauchi K; Hayashi H; Tanaka R; Nojiri S; Miyazaki T; Sumiyoshi M; Suwa S; Nakazato Y; Urabe T; Hattori N; Daida H
    J Cardiol; 2018 Jun; 71(6):590-596. PubMed ID: 29502944
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation.
    Law SWY; Lau WCY; Wong ICK; Lip GYH; Mok MT; Siu CW; Chan EW
    J Am Coll Cardiol; 2018 Jul; 72(3):271-282. PubMed ID: 30012320
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Warfarin prescription in patients with nonvalvular atrial fibrillation and one non-gender-related risk factor (CHA
    Denas G; Zoppellaro G; Padayattil Jose S; Antonucci E; Marongiu F; Poli D; Testa S; Tripodi A; Palareti G; Pengo V
    Cardiovasc Ther; 2018 Feb; 36(1):. PubMed ID: 29078033
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of real-world outcomes in patients with nonvalvular atrial fibrillation treated with direct oral anticoagulant agents or warfarin.
    Datar M; Crivera C; Rozjabek H; Abbass IM; Xu Y; Pasquale MK; Schein JR; Andrews GA
    Am J Health Syst Pharm; 2019 Feb; 76(5):275-285. PubMed ID: 30698654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Primary and secondary prevention of stroke and systemic embolism with rivaroxaban in patients with non-valvular atrial fibrillation : Sub-analysis of the EXPAND Study.
    Uchiyama S; Atarashi H; Inoue H; Kitazono T; Yamashita T; Shimizu W; Ikeda T; Kamouchi M; Kaikita K; Fukuda K; Origasa H; Shimokawa H
    Heart Vessels; 2019 Jan; 34(1):141-150. PubMed ID: 29980835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.